Cargando…
A chameleonic macrocyclic peptide with drug delivery applications
Head-to-tail cyclized peptides are intriguing natural products with unusual properties. The PawS-Derived Peptides (PDPs) are ribosomally synthesized as part of precursors for seed storage albumins in species of the daisy family, and are post-translationally excised and cyclized during proteolytic pr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132947/ https://www.ncbi.nlm.nih.gov/pubmed/34040741 http://dx.doi.org/10.1039/d1sc00692d |
_version_ | 1783694992302145536 |
---|---|
author | Payne, Colton D. Franke, Bastian Fisher, Mark F. Hajiaghaalipour, Fatemeh McAleese, Courtney E. Song, Angela Eliasson, Carl Zhang, Jingjing Jayasena, Achala S. Vadlamani, Grishma Clark, Richard J. Minchin, Rodney F. Mylne, Joshua S. Rosengren, K. Johan |
author_facet | Payne, Colton D. Franke, Bastian Fisher, Mark F. Hajiaghaalipour, Fatemeh McAleese, Courtney E. Song, Angela Eliasson, Carl Zhang, Jingjing Jayasena, Achala S. Vadlamani, Grishma Clark, Richard J. Minchin, Rodney F. Mylne, Joshua S. Rosengren, K. Johan |
author_sort | Payne, Colton D. |
collection | PubMed |
description | Head-to-tail cyclized peptides are intriguing natural products with unusual properties. The PawS-Derived Peptides (PDPs) are ribosomally synthesized as part of precursors for seed storage albumins in species of the daisy family, and are post-translationally excised and cyclized during proteolytic processing. Here we report a PDP twice the typical size and with two disulfide bonds, identified from seeds of Zinnia elegans. In water, synthetic PDP-23 forms a unique dimeric structure in which two monomers containing two β-hairpins cross-clasp and enclose a hydrophobic core, creating a square prism. This dimer can be split by addition of micelles or organic solvent and in monomeric form PDP-23 adopts open or closed V-shapes, exposing different levels of hydrophobicity dependent on conditions. This chameleonic character is unusual for disulfide-rich peptides and engenders PDP-23 with potential for cell delivery and accessing novel targets. We demonstrate this by conjugating a rhodamine dye to PDP-23, creating a stable, cell-penetrating inhibitor of the P-glycoprotein drug efflux pump. |
format | Online Article Text |
id | pubmed-8132947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-81329472021-05-25 A chameleonic macrocyclic peptide with drug delivery applications Payne, Colton D. Franke, Bastian Fisher, Mark F. Hajiaghaalipour, Fatemeh McAleese, Courtney E. Song, Angela Eliasson, Carl Zhang, Jingjing Jayasena, Achala S. Vadlamani, Grishma Clark, Richard J. Minchin, Rodney F. Mylne, Joshua S. Rosengren, K. Johan Chem Sci Chemistry Head-to-tail cyclized peptides are intriguing natural products with unusual properties. The PawS-Derived Peptides (PDPs) are ribosomally synthesized as part of precursors for seed storage albumins in species of the daisy family, and are post-translationally excised and cyclized during proteolytic processing. Here we report a PDP twice the typical size and with two disulfide bonds, identified from seeds of Zinnia elegans. In water, synthetic PDP-23 forms a unique dimeric structure in which two monomers containing two β-hairpins cross-clasp and enclose a hydrophobic core, creating a square prism. This dimer can be split by addition of micelles or organic solvent and in monomeric form PDP-23 adopts open or closed V-shapes, exposing different levels of hydrophobicity dependent on conditions. This chameleonic character is unusual for disulfide-rich peptides and engenders PDP-23 with potential for cell delivery and accessing novel targets. We demonstrate this by conjugating a rhodamine dye to PDP-23, creating a stable, cell-penetrating inhibitor of the P-glycoprotein drug efflux pump. The Royal Society of Chemistry 2021-04-11 /pmc/articles/PMC8132947/ /pubmed/34040741 http://dx.doi.org/10.1039/d1sc00692d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Payne, Colton D. Franke, Bastian Fisher, Mark F. Hajiaghaalipour, Fatemeh McAleese, Courtney E. Song, Angela Eliasson, Carl Zhang, Jingjing Jayasena, Achala S. Vadlamani, Grishma Clark, Richard J. Minchin, Rodney F. Mylne, Joshua S. Rosengren, K. Johan A chameleonic macrocyclic peptide with drug delivery applications |
title | A chameleonic macrocyclic peptide with drug delivery applications |
title_full | A chameleonic macrocyclic peptide with drug delivery applications |
title_fullStr | A chameleonic macrocyclic peptide with drug delivery applications |
title_full_unstemmed | A chameleonic macrocyclic peptide with drug delivery applications |
title_short | A chameleonic macrocyclic peptide with drug delivery applications |
title_sort | chameleonic macrocyclic peptide with drug delivery applications |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132947/ https://www.ncbi.nlm.nih.gov/pubmed/34040741 http://dx.doi.org/10.1039/d1sc00692d |
work_keys_str_mv | AT paynecoltond achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT frankebastian achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT fishermarkf achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT hajiaghaalipourfatemeh achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT mcaleesecourtneye achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT songangela achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT eliassoncarl achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT zhangjingjing achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT jayasenaachalas achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT vadlamanigrishma achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT clarkrichardj achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT minchinrodneyf achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT mylnejoshuas achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT rosengrenkjohan achameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT paynecoltond chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT frankebastian chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT fishermarkf chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT hajiaghaalipourfatemeh chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT mcaleesecourtneye chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT songangela chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT eliassoncarl chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT zhangjingjing chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT jayasenaachalas chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT vadlamanigrishma chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT clarkrichardj chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT minchinrodneyf chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT mylnejoshuas chameleonicmacrocyclicpeptidewithdrugdeliveryapplications AT rosengrenkjohan chameleonicmacrocyclicpeptidewithdrugdeliveryapplications |